RACHAEL PRIOLA: Open Payments
NPI 1952053555 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,312 in 313 payments from 21 companies in 2025. Trend: 2023 $1,721 · 2024 $4,820 · 2025 $5,312
Food & beverage: $4,540Consulting: $500Education: $272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 79 | $1,104 |
| Janssen Biotech, Inc. | 48 | $726 |
| Journey Medical Corporation | 1 | $500 |
| UCB, Inc. | 18 | $471 |
| Galderma Laboratories, L.P. | 43 | $456 |
| Novartis Pharmaceuticals Corporation | 12 | $381 |
| GENZYME CORPORATION | 18 | $380 |
| LEO Pharma Inc. | 22 | $255 |
| Lilly USA, LLC | 17 | $234 |
| Incyte Corporation | 19 | $212 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, Bimzelx, NEMLUVIO, ADBRY, OPZELURA.
Industry payments across PA — which companies pay providers there.
